|
No. |
Topic |
Summary |
Pages |
8871
| Principles of Assessing and Managing Occupational Health Risks in Potent Compound Handling | - | 39 |
8872
| Balancing manufacturing/supply and patient requirements -a risk based approach to containment using RISK-MAPP
| - | 40 |
8873
| Assessing the containment performance of pharmaceutical equipment | - | 31 |
8874
| Case Study 1: Highly potent APIs: Containment requirements from development to production
| - | 51 |
8875
| Case Study 2: Pfizer NEWCON Illertissen, a new milestone in pharmaceutical engineering | - | 36 |
8876
| Case Study 3: Containment for Sterile Manufacturing Operations | - | - |
8877
| Case Study 4: DevCon - a case study at Pfizer, Freiburg
| - | 33 |
10414
| Case study 5: A Biosafety Level 3 Pilot Containment Facility for Biologicals
| - | 52 |
